Starling Oncology, Inc. Increase (Decrease) in Income Taxes Payable
Starling Oncology, Inc. (STLN) reported Increase (Decrease) in Income Taxes Payable of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable · last filed 2025-03-26
- Starling Oncology, Inc. increase (decrease) in income taxes payable for the quarter ending 2023-12-31 was -$255.00K.
- Starling Oncology, Inc. increase (decrease) in income taxes payable for the quarter ending 2023-09-30 was -$1.00K, a 100.39% decline year-over-year.
- Starling Oncology, Inc. increase (decrease) in income taxes payable for the quarter ending 2022-12-31 was -$132.00K.
- Starling Oncology, Inc. increase (decrease) in income taxes payable for the quarter ending 2022-09-30 was $255.00K, a 94.18% decline year-over-year.
- Starling Oncology, Inc. increase (decrease) in income taxes payable for fiscal 2024 was $0.00.
- Starling Oncology, Inc. increase (decrease) in income taxes payable for fiscal 2023 was -$255.00K, a 307.32% decline from fiscal 2022.
- Starling Oncology, Inc. increase (decrease) in income taxes payable for fiscal 2022 was $123.00K.
- Starling Oncology, Inc. increase (decrease) in income taxes payable for fiscal 2021 was -$1.01M, a 254.50% decline from fiscal 2020.
| Period end | Increase (Decrease) in Income Taxes Payable 3 month | Increase (Decrease) in Income Taxes Payable 6 month | Increase (Decrease) in Income Taxes Payable 9 month | Increase (Decrease) in Income Taxes Payable 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-26 | |||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-13 | |||
| 2023-12-31 | -$255.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | -$256.00K derived: sum of 2 quarters · filed 2025-03-26 | -$255.00K 10-K · filed 2025-03-26 | |
| 2023-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $0.00 10-Q · filed 2023-11-08 | ||
| 2023-06-30 | $1.00K 10-Q · filed 2024-08-13 | |||
| 2022-12-31 | -$132.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $123.00K derived: sum of 2 quarters · filed 2024-03-28 | $123.00K derived: sum of 3 quarters · filed 2024-03-28 | $123.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $255.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $255.00K derived: sum of 2 quarters · filed 2023-11-08 | $255.00K 10-Q · filed 2023-11-08 | -$5.77M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | -$6.03M derived: sum of 3 quarters · filed 2023-08-09 | -$1.65M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-10 | -$6.03M derived: sum of 2 quarters · filed 2023-03-16 | -$1.65M derived: sum of 3 quarters · filed 2023-03-16 | -$1.11M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-12-31 | -$6.03M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$1.65M derived: sum of 2 quarters · filed 2023-03-16 | -$1.11M derived: sum of 3 quarters · filed 2023-03-16 | -$1.01M 10-K · filed 2023-03-16 |
| 2021-09-30 | $4.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $4.91M derived: sum of 2 quarters · filed 2022-11-09 | $5.01M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $532.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $634.00K 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $102.00K 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $655.00K 10-K · filed 2022-03-11 |